NCT04666896

Brief Summary

For hEDS or HSD patients with MDI, a multidisciplinary treatment approach is suggested. As follows, physiotherapy plays a key role in this integrative management. Nevertheless, knowledge regarding EDS is limited among health care professionals. Consequently, evidence-based treatment approaches for the hEDS/HSD population are scarce. Therefore, the aim of this study is to compare two different home-based exercise programs in order to increase our knowledge regarding treatment options, and to gain insight in safe, effective exercises for the unstable shoulder in this study population.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 9, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 9, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 14, 2020

Completed
Last Updated

March 22, 2021

Status Verified

March 1, 2021

Enrollment Period

1.2 years

First QC Date

December 8, 2020

Last Update Submit

March 17, 2021

Conditions

Keywords

Hypermobile Ehlers-Danlos syndromeHypermobility Spectrum DisorderMutlidirectional shoulder instabilityTelerehabilitation

Outcome Measures

Primary Outcomes (1)

  • Change in Western Ontario Shoulder Instability Index (WOSI)

    The WOSI is a responsive patient-reported and disease-specific tool, designed to be used as the primary outcome measure in clinical trials that assess treatments for patients with shoulder instability. Range 0 - 2100 points. Higher scores express worse status.

    Measured at baseline, 6 weeks, 12 weeks and 24 weeks, in order to assess the change in WOSI from baseline to 6 weeks, 12 weeks, and 24 weeks

Secondary Outcomes (5)

  • The Disabilities of the Arm Shoulder and Hand (DASH)

    Measured at baseline, 6 weeks, 12 weeks and 24 weeks

  • The Tampa Scale for Kinesiophobia (TSK)

    Measured at baseline, 6 weeks, 12 weeks and 24 weeks

  • The Patient-Specific Functional Scale (PSFS)

    Measured at baseline, 6 weeks, 12 weeks and 24 weeks

  • The Global Rating of Change (GROC)

    Measured at baseline, 6 weeks, 12 weeks and 24 weeks

  • Pain pressure thresholds (PPT)

    Measured at baseline, 6 weeks, 12 weeks and 24 weeks

Study Arms (2)

Evidence-based tailored care (group A)

EXPERIMENTAL

Patients who were randomized to group A received a tailored exercise program, with exercises developed based on recent hEDS/HSD research data.

Other: Tailored home-based exercise therapy

Evidence-based standard care (group B)

ACTIVE COMPARATOR

This exercise program was composed in order to reflect evidence-based standard care, in a telerehabilitation format.

Other: Standard home-based exercise therapy

Interventions

exercises were divided into four types: 1) shrug exercises; 2) external rotation exercises; 3) bench slides; and 4) wall slides.

Evidence-based tailored care (group A)

The exercise program consisted of 4 types of exercises for training 1) balance and proprioception; 2) isometric strength; 3) rotator cuff muscles; and 4) open chain elevation

Evidence-based standard care (group B)

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsGender 'female' on ID (passport)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • years
  • Patients diagnosed by a medical doctor with generalized HSD or hEDS, according to the diagnostic criteria for hEDS and HSD as stated in the recently published international classification for the Ehlers-Danlos syndromes
  • Patients diagnosed with multidirctional shoulder instability (MDI): The diagnosis of MDI was confirmed when 1) patients reported symptoms of shoulder instability in daily life (e.g. recurrent subluxations) without a traumatic onset; 2) patients scored positive on shoulder laxity and instability tests (i.e. sulcus sign, anterior and posterior load and shift, posterior jerk, Gagey hyperabduction test, passive and active external rotation in supine, apprehension and relocation test) in at least two directions; 3) patients had shoulder pain for at least three months prior to the study.

You may not qualify if:

  • pregnancy during study participation
  • patients who started a new physiotherapeutic treatment in the 2 weeks prior to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghent University, department of rehabilitation sciences

Ghent, Oost-Vlaanderen, 9000, Belgium

Location

MeSH Terms

Conditions

Ehlers-Danlos syndrome type 3

Study Officials

  • Fransiska Malfait, Prof. Dr.

    Centre of Medical Genetics

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2020

First Posted

December 14, 2020

Study Start

May 9, 2019

Primary Completion

July 9, 2020

Study Completion

July 9, 2020

Last Updated

March 22, 2021

Record last verified: 2021-03

Locations